Dr. Beth Karlan is a leader in the field of research on early detection of ovarian cancer. She has received research grants from the Department of Defense, National Institutes of Health and the American Cancer Institute. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. This year, she is our winner of the Rosalind Franklin Excellence in Ovarian Cancer Research Award due to her commitment to innovative ovarian cancer research.
Related Topics
The Overview: June 2025
OCRA Featured in Fortune Article on Surgery That Reduces Ovarian Cancer Risk Ovarian Cancer Research Alliance’s (OCRA) leadership in raising awareness about opportunistic salpingectomy—a simple procedure that can significantly reduce … Continued
OCRA Featured in Fortune on Surgery That Reduces Ovarian Cancer Risk
A Fortune article published on June 16, 2025, titled I had one simple surgery to lower my risk of the deadliest cancer for women. Here’s why you probably don’t know … Continued
Ovarian Cancer Research Alliance Partners with Iris by OncoHealth to Expand Access to the Steps Counseling Program
New collaboration enhances support for gynecologic cancer patients through integrated digital and personalized care New York, NY — [June 11, 2025] — Ovarian Cancer Research Alliance (OCRA), the largest global organization … Continued